Sun Pharmaceutical Industries logo

Sun Pharmaceutical Industries share news, announcements and annual reports

NSE: SUNPHARMABSE: 524715Pharmaceuticals & BiotechnologyLarge Cap

Sun Pharmaceutical Industries Limited · Formerly Sun Pharmaceuticals Industries · Face value ₹1 · Listed Dec 1994 on BSE, Feb 1995 on NSE
Last close ₹1,761.00up ₹3.50 (0.20%)BSE ₹1,762.95

Share price at the NSE close on 29 Oct 2026. Previous close ₹1,757.50.

29 Oct: open ₹1,757.50, high ₹1,771.50, low ₹1,752.70

52-week range of traded prices to 29 Oct 2026
₹1,583.70Low, 29 Jan 2026₹2,046.90High, 31 Jul 2026
Market cap
₹4,22,523 Cr13th largest listed
P/E
34.93
P/B
5.06
Dividend yield
0.91%
ROE
15.5%
ROCE
16.9%
Debt to equity
0.05
Volume, NSE
11,07,85459.5% delivered

Sun Pharmaceutical Industries share news and announcements

1,448 announcements, routine notices left out, newest first. Page 29 of 29.

  1. Oct 2007

    • 25 Oct · Results

      Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 54128 lacs for quarter ending on 30-SEP-2007 against Rs. 40599 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 19483 lacs for the quarter ending on 30-SEP-2007 against Rs. 16011 lacs for the quarter ending on 30-SEP-2006.

    • 23 Oct · Business

      Press release dated October 23, 2007, titled "Sun Pharma announces USFDA approval to market generic Exelon Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 22 Oct · Allotment of Equity Shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held on October 20, 2007, has allotted 864,034 (Eight Lacs Sixty Four Thousand Thirty Four) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 14,000 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,95,25,382 Equity Shares of Rs.5/- each to 20,03,89,416 Equity Shares of Rs.5/- each, as of date

    • 17 Oct · Business

      Press release dated October 16, 2007, titled "Sun Pharma receives "will-not-sue" covenant on generic Effexor XR ANDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 15 Oct · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held on October 14, 2007, has allotted 339,441 (Three Lakhs Thirty Nine Thousand Four Hundred and Forty One) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 5,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,91,85,941 Equity Shares of Rs.5/- each to 19,95,25,382 Equity Shares of Rs.5/- each, as of date

    • 10 Oct · Business

      Press release dated October 10, 2007, titled "Sun pharma announces USFDA approval to market generic Trileptal (R) Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 9 Oct · Board meeting

      Interalia, (i) to consider and take on record the un-audited financial results of the Company for the half year / second quarter ended September 30, 2007. (ii) to consider payment of interim dividend @ 6% p.a. on outstanding 1,37,40,030 Preference Shares of Re.1/- each to those Preference shareholders holding Preference Shares as on November 01, 2007 on prorata basis for the period from April 01, 2007 to November 01, 2007 i.e. the date of compulsory redemption by the Company.

    • 8 Oct · Miscellaneous

      Circular letter regarding Redemption of Preference Shares of Re.1/- each which are being posted to all the Preference shareholders of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  2. Sep 2007

    • 27 Sep · Business

      Press release dated September 26, 2007, titled "Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 17 Sep · Suspension

      Members of the Exchange are hereby informed that the trading in the 6% Cumulative Redeemable Preference Shares (Series-P1) of Sun Pharmaceuticals Industries Ltd. shall be suspended w.e.f. October 05, 2007 on account of redemption.

    • 11 Sep · Corporate action

      Company has fixed October 12, 2007 as the Record Date for the purpose of reckoning the names of the Preference Shareholders of Sun Pharmaceuticals Industries Ltd. (SPIL) who shall be entitled to receive the redemption proceeds of preference shares of Re.1/- each at par value on the due date of redemption on November 1, 2007 and thereafter no transfers could be effected/valid. Further the Company has decided to redeem the outstanding Preference Shares of Re.1/- each at par value without calling for preference share certificates in physical form or without asking for credit to specified account for redemption in case of preference shares in de-mat form.

    • 6 Sep · Meeting

      Report of the proceedings of the Annual General Meeting (AGM) of the Company held on September 05, 2007. A report of proceedings shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  3. Aug 2007

    • 13 Aug · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, August 11, 2007, has allotted 1,247,972 (One Million Two Hundred Forty Seven Thousand Nine Hundred and Seventy Two) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 20,221 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,79,37,969 Equity Shares of Rs.5/- each to 19,91,85,941 Equity Shares of Rs.5/- each, as of date

    • 2 Aug · Meeting

      Register of Equity and Preference members and Share Transfer Books of the Company in respect of Equity and Preference Shares will remain closed from August 30, 2007 to September 05, 2007 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 05, 2007.

  4. Jul 2007

    • 28 Jul · Meeting

      Report of the proceedings of the Extraordinary General Meeting (EGM) of the Company held on July 28, 2007. A report of proceedings shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 23 Jul · Results

      Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 50881 lacs for quarter ending on 30-JUN-2007 against Rs. 54087 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 22539 lacs for the quarter ending on 30-JUN-2007 against Rs. 14802 lacs for the quarter ending on 30-JUN-2006.

    • 23 Jul · Results

      Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 62750 lacs for quarter ending on 30-JUN-2007 against Rs. 51164 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 22720 lacs for the quarter ending on 30-JUN-2007 against Rs. 17673 lacs for the quarter ending on 30-JUN-2006.

    • 23 Jul · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, July 21, 2007, has allotted 842,430 (Eight Hundred Forty Two Thousand Four Hundred and Thirty) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 13,650 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,70,95,539 Equity Shares of Rs.5/- each to 19,79,37,969 Equity Shares of Rs.5/- each, as of date

    • 11 Jul · Board meeting

      Meeting on 23 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”

    • 9 Jul · Meeting

      Notice of the Extraordinary General Meeting of the Equity shareholders of the Company to be held on July 28, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 4 Jul · Raising of Funds/Others

      July 03, 2007, that: "At the meeting of the Board of Directors of the Company held today, the Board decided to raise funds by issue of global depository receipts / debentures / bonds / securities whether partly / optionally / fully convertible into equity shares and/or securities linked to equity shares and/or foreign currency convertible bonds and/or bonds with share warrants attached and/or any other equity share related instruments, secured or unsecured either by way of private placement or otherwise in course of offer in domestic / international markets in one or more tranches to Indian/Foreign Investors through Global Depository Receipts or such other manner either in Rupee or in Foreign currency denomination, subject to the approvals of the Shareholders, Government of India, Reserve Bank of India, Securities and Exchange Board of India and/or any other authorities, institutions or bodies as may be relevant and subject to applicable regulations, so however that the total amount raised through the aforesaid securities should not exceed Rupees 35,000 (Thirty Five Thousand) Million. The Board also decided to hold an Extra Ordinary General Meeting at Mumbai, for seeking the shareholders' approval to the above issue".

  5. Jun 2007

    • 29 Jun · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, June 28, 2007, has allotted 1,018,323 (Ten Lacs Eighteen Thousand Three Hundred and Twenty Three) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 16,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,60,77,216 Equity Shares of Rs.5/- each to 19,70,95,539 Equity Shares of Rs.5/- each, as of date

    • 11 Jun · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, June 09, 2007, has allotted 1,139,901 (Eleven Lacs Thirty Nine Thousand Nine Hundred and One) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 18,470 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,49,37,315 Equity Shares of Rs.5/- each to 19,60,77,216 Equity Shares of Rs.5/- each, as of date

    • 1 Jun · Miscellaneous

      Copy of transcript of the conference call held on May 21, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  6. May 2007

    • 21 May · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, May 19, 2007, has allotted 5,18,417 (Five Lacs Eighteen Thousand Four Hundred And Seventeen) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 8,400 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,44,18,898 Equity Shares of Rs.5/- each to 19,49,37,315 Equity Shares of Rs.5/- each, as of date

    • 21 May · Business

      "We, Sun Pharmaceutical Industries Limited has along with our subsidiary companies signed definitive agreements to acquire Taro Pharmaceutical Industries Limited, a multinational generic manufacturer with established subsidiaries, manufacturing and products across the U.S., Israel, Canada". Further, a copy of the press release dated May 21, 2007, titled "Sun Pharma to acquire Taro Pharma in a USD 454 million deal" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.

    • 18 May · Business

      Press release, dated May 18, 2007, titled "All round growth, R&D demerger mark year at Sun Pharma." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 14 May · Board meeting

      Company had informed the Exchange regarding a Board Meeting scheduled to be held on May 15, 2007. The company has now informed the Exchange that: "The proposed Meeting of the Board of Directors of the Company which was to be held on Tuesday, 15th May, 2007, interalia, to consider the audited financial results of the Company for the year ended 31st March, 2007 has been postponed and will now be held on Friday, 18th May 2007".

  7. Apr 2007

    • 30 Apr · Board meeting

      Interalia, to consider the audited financial results of the Company for the year ended March 31, 2007.

    • 26 Apr · Allotment of Equity Shares

      10,16,778 Equity Shares of Rs. 5/- each issued and allotted at the Meeting of the Committee of Directors (Allotment) held on April 21, 2007 upon conversion 16,475 FCCBs, shall rank pari-passu with the existing equity shares of the company including dividend.

    • 21 Apr · Allotment of Equity Shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, April 21, 2007 has allotted 10,16,778 (Ten Lacs Sixteen Thousand Seven Hundred And Seventy Eight) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 16,475 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,34,02,120 Equity Shares of Rs.5/- each to 19,44,18,898 Equity Shares of Rs 5/- each, as of date

    • 5 Apr · Business

      Hon'ble High Court of Gujarat, at Ahemdabad at its hearing held on 1st March, 2007 approved the Scheme of Arrangement between Sun Pharmaceutical Industries Limited (SPIL) and Sun Pharma Advanced Research Company Limited (SPARC) in the nature of demerger and transfer of Innovative Research and Development (Including New Drug Delivery Systems) Business/Unit of SPIL to SPARC with appointed date of 28th February, 2007. Further the Company informed the Exchange that vide letter dated March 30, 2007, the Company has fixed Monday, 30th April, 2007 as the Record Date for the purpose of reckoning the names of the equity shareholders of SPIL who shall be entitled to receive the equity shares of Re. 1/- each of SPARC in the ratio of 1:1. It also informed that the Company has decided to fix up the closed Period pursuant to the Sub Clause (iii) of Para 2 of Clause 6 A (i) of the Terms and Conditions of the Bonds as appearing in the Offering Circular dated 24th November, 2004 in respect of Zero Coupon Foreign Currency Convertible Bonds due 2009 from Thursday 19th April, 2007 to 30th April, 2007 (both days inclusive) and therefore the right to convert any such Bonds into the shares of the Company may not be exercised during the said closed Period.

    • 2 Apr · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, March 31, 2007 has allotted 864,340 (Eight Lacs Sixty Four Thousand Three hundred and Forty) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 14,005 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,25,37,780 Equity Shares of Rs.5/- each to 19,34,02,120 Equity Shares of Rs 5/- each, as of date

  8. Mar 2007

    • 30 Mar · Business

      Hon'ble High Court of Gujarat, at Ahmedabad at its hearing held on March 01, 2007 approved the Scheme of Arrangement between Sun Pharmaceutical Industries Limited (SPIL) and Sun Pharma Advanced Research Company Limited (SPARC) in the nature of demerger and transfer of innovative Research and Development (including New Drug Delivery Systems) Business/Unit of SPIL to SPARC with appointed date of February 28, 2007. The certified copy of the order dated March 28, 2007 of the Hon'ble High Court has been filed electronically by SPIL & SPARC with the Registrar of Companies on March 29, 2007. Further, April 30, 2007 has been fixed as the Record Date as for the purpose of reckoning the names of the equity shareholders of SPIL who shall be entitled to receive the equity shares of Re.1/- each of SPARC in the ratio of 1:1 i.e. all the equity shareholders of SPIL whose names stand registered on the SPIL's Register of Members as Beneficial Owners as at the closing of business as on April 30, 2007 as per the list provided by National Securities Depository Limited and Central Depository Services (India) Limited in respect of the shares held in electronic form and as Members in the Register of Members of SPIL after giving effect to valid transfers in physical form lodged with the Company on or before April 30, 2007 will be allotted 1 (One) no. of Equity share of Re. 1/- (One) each of SPARC for every 1 (one) no. of equity share of Rs.5/- each of SPIL. A note on the scheme of Arrangement shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 27 Mar · E-mail ID for Investor Complaints

      The Company has created separate e-mail ID of the Grievance Division/Compliance Officer in which the investor would be able to lodge the complaint and also to take up necessary follow-up, namely secretarial@sunpharma.com which has been displayed prominently on the website of the Company i.e. at www.sunpharma.com.

    • 12 Mar · Business

      Press release dated March 10, 2007, titled "Sun Pharma to host a Management Presentation sharing NCE and NDDS program details". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 10 Mar · Dividend

      Board of Directors of the Company at its meeting held on March 10, 2007, declared an interim dividend @ 6% p.a. on the outstanding 6% Cumulative Redeemable Preference Shares of Re.1/- each and @ 135% on equity shares of Rs.5/- each i.e. Rs.6.75 per equity share of Rs.5/- each of the company for the year ended March 31, 2007.

    • 9 Mar · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, March 09, 2007 has allotted 277,725 (Two Lacs Seventy Seven Thousand Seven Hundred and Twenty Five) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 4,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,22,60,055 Equity Shares of Rs.5/- each to 19,25,37,780 Equity Shares of Rs 5/- each, as of date

    • 2 Mar · Board meeting

      Interalia, to consider payment of Interim Dividend on outstanding Preference Shares of Re.1/- each and on Equity Shares of Rs.5/- each for the year ending March 31, 2007. The Preference and the Equity Shareholders of the Company holding shares as on March 16, 2007, being the Record Date, will be eligible to receive such Interim Dividend as may be declared by the board at the above Meeting.

  9. Feb 2007

    • 23 Feb · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, February 23, 2007 has allotted 135,467 (One Lac Thirty Five Thousand Four Hundred and Sixty Seven) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 2,195 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,21,24,588 Equity Shares of Rs.5/- each to 19,22,60,055 Equity Shares of Rs 5/- each, as of date

    • 22 Feb · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, February 22, 2007 has allotted 222,179 (Two Lacs Twenty Two Thousand One Hundred and Seventy Nine) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 3,600 Zero Coupon Foreign Currency SUNPHARMA : Sun Pharmaceuticals Industries Ltd has informed the Exchange that: "Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, February 22, 2007 has allotted 222,179 (Two Lacs Twenty Two Thousand One Hundred and Seventy Nine) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 3,600 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,19,02,409 Equity Shares of Rs.5/- each to 19,21,24,588 Equity Shares of Rs 5/- each, as of date".Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,19,02,409 Equity Shares of Rs.5/- each to 19,21,24,588 Equity Shares of Rs 5/- each, as of date

    • 6 Feb · Utilisation of Funds

      During the quarter, out of the USD 350 Million Zero Coupon Foreign Currency Convertible Bonds issued by the company, the holders of USD 55.0 Million have exercised conversion option and consequently 3,396,806 Equity Shares of Rs. 5 each were allotted to them as per the terms of the issue at a Premium of Rs. 724.3 per Share. Subsequent to December 31, 2006 Zero Coupon Foreign Currency Convertible Bonds of USD 19.8 Million have been converted into 1,221,986 Equity Shares of Rs. 5 each and consequently the paid up Share Capital and the Securities Premium account as on date stands at Rs. 956.4 Million and Rs. 4174.5 Million respectively.

    • 5 Feb · Allotment of shares

      Pursuant to the terms and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today i.e February 03, 2007 has allotted 623,333 (Six Lacs Twenty Three Thousand Three Hundred and Thirty Three) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 10,100 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,12,79,076 Equity Shares of Rs.5/- each to 19,19,02,409 Equity Shares of Rs 5/- each, as of date

  10. Jan 2007

    • 25 Jan · Redemption

      The Company has redeemed at par 86,676 number of 6% Cumulative Redeemable Preference Shares of Re.1/- each amounting to Rs.86,676/- (Rupees Eighty Six Thousand Six Hundred Seventy Six Only) pursuant to the offer of redemption provided from 1st October, 2006 to 31st December, 2006, under third lot out of the total paid-up Preference Share Capital of Rs.1,38,26,706/- consisting of 1,38,26,706 - 6% Cumulative Redeemable Preference Shares of Re.1/- each, thus reduces the Preference Shares from 1,38,26,706 - to 1,37,40,030

    • 19 Jan · Allotment of shares

      Pursuant to the terms. and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, January 19, 2007 has allotted 216,008 (Two Lacs Sixteen Thousand Eight) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 3,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,10,63,068 Equity Shares of Rs.5/- each to 19,12,79,076 Equity Shares of Rs 5/- each, as of date

    • 18 Jan · Allotment of shares

      Pursuant to the terms. and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, January 18, 2007 has allotted 706,654 (Seven Lacs Six Thousand Six Hundred & Fifty Four) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 11,450 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,03,56,414 Equity Shares of Rs.5/- each to 19,10,63,068 Equity Shares of Rs 5/- each, as of date

    • 15 Jan · Board meeting

      Meeting on 29 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”

    • 9 Jan · Allotment of shares

      Pursuant to the terms. and conditions of the Offering Circular dated November 24, 2004, the Committee of Directors (Allotment) of the Company at its meeting held today, January 09, 2007 has allotted 299,324 (Two Lacs, Ninety Nine Thousand Three Hundred & Twenty Four) Equity Shares of Rs.5/- each of the Company at a premium of Rs.724.30 per share upon exercise of option of conversion for 4,850 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) into Equity shares of the Company by FCCB holders. Consequently, the paid up Equity Share Capital of the Company has increased from 19,00,57,090 Equity Shares of Rs.5/- each to 19,03,56,414 Equity Shares of Rs 5/- each, as of date